跳至主要内容
临床试验/NCT05175937
NCT05175937招募中不适用

REal World Assessment for Patients Implanted With Implantable CardioverTer DefibrIllatOr Using Bluetooth Technology

Federico II University1 个研究点 分布在 1 个国家目标入组 1,104 人开始时间: 2021年9月22日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,104
试验地点
1
主要终点
Effectiveness

研究概览

简要总结

The objective of this observational study is to assess clinical benefits of innovative features (e.g. Bluetooth technology and smartphone patient applications) in a patient population that is implanted with standard indication for implantable cardiac defibrillator.

详细描述

REACTION is an observational study in which patients will be followed as for clinical practice and no specific study tests/procedures will be perfprmed. After implanting a device, the patient will be assigned to an arm or to the other based on the technology of the device (bluetooth or RF) he/she wears, if he/she gives the consent to partecipate. It is not a randomized study. Patients will be enrolled consecutively until reaching the sample defined for both the arms.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients implanted with an ICD as for standard indications
  • Over 18 years of age
  • Ability to provide informed consent for registry participation and be willing and able to comply with the protocol described evaluations

排除标准

  • Subject who is, or is expected to be inaccessible for follow-up
  • pregnancy

结局指标

主要结局

Effectiveness

时间窗: 12 months

The effectiveness based on the comparison between the App monitoring and the traditional remote control will be assessed through the following endpoints: • Percentage of time (days) with an active connection between device and the transmitter/smartphone app

Adherence

时间窗: 12 months

The adherence will be measured through the following endpoints: • Compliance with RM quantified as percentage of patients who registered with the smartphone App

次要结局

  • Clinical benefits in CRT area:(12 Months)
  • Clinical benefits in ICD therapies(12 months)

研究者

发起方
Federico II University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Antonio Rapacciuolo

Principal Investigator

Federico II University

研究点 (1)

Loading locations...

相似试验